<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4157">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04733846</url>
  </required_header>
  <id_info>
    <org_study_id>IRBN202021</org_study_id>
    <nct_id>NCT04733846</nct_id>
  </id_info>
  <brief_title>Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy</brief_title>
  <official_title>Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vicryl (polyglactin) 10-0 resorbable suture is rarely used, little known to ophthalmologists&#xD;
      but may offer therapeutic and practical advantages in eligible cases of corneal trauma,&#xD;
      particularly during a COVID-19 pandemic.&#xD;
&#xD;
      This has imposed new sanitary restrictions : limited access to the operating room in&#xD;
      ophthalmology only for functional emergencies and a drastically reduced capacity for external&#xD;
      consultations in favor of teleconsultation. The aim of this study is to evaluate the Vicryl&#xD;
      10-0 (polyglactin 910) resorbable monofilament suture in corneal trauma, rather than classic&#xD;
      Nylon 10-0: structural and functional results, and adaptation of postoperative follow-up&#xD;
      during a sanitary crisis period.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual acuity (Snellen scale)</measure>
    <time_frame>Month: 3</time_frame>
    <description>Collected in the medical record pre and post operating.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual acuity (Paarinaud) scale</measure>
    <time_frame>Month: 3</time_frame>
    <description>Collected in the medical record pre and post operating.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Astigmatism (diopter)</measure>
    <time_frame>Month: 3</time_frame>
    <description>Collected in the medical record at post operating. Measured by OCT-TOMEY-CASIA).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of postoperative external consultations</measure>
    <time_frame>From surgery to Month 3</time_frame>
    <description>Collected in the medical record.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>From surgery to Month 3</time_frame>
    <description>Collected in the medical record. All adverse events connecting to the eye surgery.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">9</enrollment>
  <condition>Eye Trauma</condition>
  <arm_group>
    <arm_group_label>corneal trauma sutured with Vicryl 10-0 monofilament</arm_group_label>
    <description>corneal trauma sutured with Vicryl 10-0 monofilament will be included. They will have data collection of medical records.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>data collection</intervention_name>
    <description>Collection of clinical and paraclinical data during preoperative consultation Collection of clinical and paraclinical data during post-operative consultations Tele-consultation to determine if criteria for good healing / adherence, treatment tolerance / response to questions Remote follow-up 6 and 12 months after the trauma</description>
    <arm_group_label>corneal trauma sutured with Vicryl 10-0 monofilament</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who had an emergency eye surgery in the Saint-Etienne University Hospital from&#xD;
        18/03/2020 to 05/12/20&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Corneal penetrating injury and/or lamellar laceration, or corneal melting in&#xD;
             inflammatory diseases&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Corneal Penetrating injury trauma requiring necessarily Nylon 10-0&#xD;
&#xD;
          -  Traumatism requiring a cryopreserved human amniotic membrane&#xD;
&#xD;
          -  Traumatism eligible for biological glue (wound &lt; 2 mm)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thibaut GARCIN, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thibaut GARCIN, MD PhD</last_name>
    <phone>(0)477127793</phone>
    <phone_ext>+33</phone_ext>
    <email>Thibaud.Garcin@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Caroline TRONE, MD</last_name>
    <phone>(0)477829428</phone>
    <phone_ext>+33</phone_ext>
    <email>m.caroline.trone@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Ã‰tienne</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Thibaut GARCIN, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philippe GAIN, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gilles THURET, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas ABIHAIDAR, resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 2, 2021</study_first_posted>
  <last_update_submitted>February 2, 2021</last_update_submitted>
  <last_update_submitted_qc>February 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Corneal</keyword>
  <keyword>penetrating injury</keyword>
  <keyword>lamellar laceration</keyword>
  <keyword>COVID</keyword>
  <keyword>polyglactin</keyword>
  <keyword>Vicryl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

